In recurrent glioma, the probability of survival was higher in the TUBA1C low expression group in all WHO grades (Fig. 14M, p < 0.0001) and the WHO grade III (Fig. 14Q, p = 0.012) subclassification. Here, TUBA1C is linked to glioma.